Publicaciones en colaboración con investigadores/as de Technical University Munich (18)

2024

  1. Relapse in clinically stable adult patients with schizophrenia or schizoaffective disorder: evidence-based criteria derived by equipercentile linking and diagnostic test accuracy meta-analysis

    The Lancet Psychiatry, Vol. 11, Núm. 1, pp. 36-46

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Optimizing subjective wellbeing with amisulpride in first episode schizophrenia or related disorders

    Psychological Medicine, Vol. 53, Núm. 13, pp. 5986-5991

2022

  1. Novel genes and sex differences in COVID-19 severity

    Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806

2021

  1. Identification and management of cardiometabolic risk in subjects with schizophrenia spectrum disorders: A Delphi expert consensus study

    European psychiatry : the journal of the Association of European Psychiatrists, Vol. 64, Núm. 1, pp. e7

  2. The role of depression in the prediction of a “late” remission in first-episode psychosis: An analysis of the OPTiMiSE study

    Schizophrenia Research, Vol. 231, pp. 100-107

2020

  1. Hostility and aggressive behaviour in first episode psychosis: Results from the OPTiMiSE trial

    Schizophrenia Research, Vol. 223, pp. 271-278

  2. Persistent negative symptoms in recent-onset psychosis: Relationship to treatment response and psychosocial functioning

    European Neuropsychopharmacology, Vol. 34, pp. 76-86

  3. Placebo response in pharmacological and dietary supplement trials of autism spectrum disorder (ASD): Systematic review and meta-regression analysis

    Molecular Autism, Vol. 11, Núm. 1

  4. Rasch analysis of the PANSS negative subscale and exploration of negative symptom trajectories in first-episode schizophrenia – data from the OPTiMiSE trial

    Psychiatry Research, Vol. 289

2019

  1. Correction: Stratification and prediction of remission in first-episode psychosis patients: the OPTiMiSE cohort study (Translational Psychiatry, (2019), 9, 1, (20), 10.1038/s41398-018-0366-5)

    Translational Psychiatry

  2. Stratification and prediction of remission in first-episode psychosis patients: the OPTiMiSE cohort study

    Translational Psychiatry, Vol. 9, Núm. 1

2018

  1. Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): a three-phase switching study

    The Lancet Psychiatry, Vol. 5, Núm. 10, pp. 797-807

2015

  1. Magnetic resonance imaging and the prediction of outcome in first-episode schizophrenia: A review of current evidence and directions for future research

    Schizophrenia Bulletin, Vol. 41, Núm. 3, pp. 574-583

  2. Modeling determinants of medication attitudes and poor adherence in early nonaffective psychosis: Implications for intervention

    Schizophrenia Bulletin, Vol. 41, Núm. 3, pp. 584-596

2013

  1. Issues and perspectives in designing clinical trials for negative symptoms in schizophrenia

    Schizophrenia Research, Vol. 150, Núm. 2-3, pp. 328-333

2009

  1. Advantages and disadvantages of combination treatment with antipsychotics. ECNP Consensus Meeting, March 2008, Nice

    European Neuropsychopharmacology, Vol. 19, Núm. 7, pp. 520-532

2006

  1. Standardized remission criteria in schizophrenia

    Acta Psychiatrica Scandinavica, Vol. 113, Núm. 2, pp. 91-95